Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer cancer drug fails in 2 late-stage studies, results from 3rd trial expected in 2015
Pfizer cancer drug fails in 2 late-stage studies, results from 3rd trial expected in 2015
Pfizer cancer drug fails in 2 late-stage studies, results from 3rd trial expected in 2015
Submitted by
admin
on January 27, 2014 - 8:54am
Source:
Yahoo/AP
News Tags:
Pfizer
dacomitinib
erlotinib
non-small cell lung cancer
Headline:
Pfizer cancer drug fails in 2 late-stage studies, results from 3rd trial expected in 2015
Do Not Allow Advertisers to Use My Personal information
